Clinical Trial Detail

NCT ID NCT02768389
Title Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

glioblastoma multiforme

malignant glioma

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.